Literature DB >> 14684791

Breakthrough of the year. SARS: a pandemic prevented.

Martin Enserink.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 14684791     DOI: 10.1126/science.302.5653.2045

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

1.  A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.

Authors:  Parag P Shah; Tianhua Wang; Rachel L Kaletsky; Michael C Myers; Jeremy E Purvis; Huiyan Jing; Donna M Huryn; Doron C Greenbaum; Amos B Smith; Paul Bates; Scott L Diamond
Journal:  Mol Pharmacol       Date:  2010-05-13       Impact factor: 4.436

Review 2.  The aetiology, origins, and diagnosis of severe acute respiratory syndrome.

Authors:  L L M Poon; Y Guan; J M Nicholls; K Y Yuen; J S M Peiris
Journal:  Lancet Infect Dis       Date:  2004-11       Impact factor: 25.071

3.  Impact of quarantine on the 2003 SARS outbreak: a retrospective modeling study.

Authors:  Ying-Hen Hsieh; Chwan-Chuan King; Cathy W S Chen; Mei-Shang Ho; Sze-Bi Hsu; Yi-Chun Wu
Journal:  J Theor Biol       Date:  2006-09-16       Impact factor: 2.691

Review 4.  Development of virus-like particles-based vaccines against coronaviruses.

Authors:  Chean Yeah Yong; Winnie Pui Pui Liew; Hui Kian Ong; Chit Laa Poh
Journal:  Biotechnol Prog       Date:  2022-08-05

5.  Quarantine for SARS, Taiwan.

Authors:  Ying-Hen Hsieh; Chwan-Chuan King; Cathy W S Chen; Mei-Shang Ho; Jen-Yu Lee; Feng-Chi Liu; Yi-Chun Wu; Jiunn-Shyan JulianWu
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

6. 

Authors:  E Navas Elorza
Journal:  FMC       Date:  2013-04-03

Review 7.  Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

Authors:  Tommy R Tong
Journal:  Perspect Med Virol       Date:  2006-11-28

8.  Caminante no hay camino, se hace camino al andar.

Authors:  Rodolfo Saracci
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.